LUYAN PHARMA released its first-quarter performance, with a net profit attributable to the parent company of 71.3236 million yuan, a decrease of 14.86%
I'm PortAI, I can summarize articles.
LUYAN PHARMA released its Q1 2025 performance report, with operating revenue of 5.174 billion yuan, a year-on-year increase of 0.74%. The net profit attributable to the parent company was 71.3236 million yuan, a year-on-year decrease of 14.86%; the net profit after deducting non-recurring gains and losses was 70.8861 million yuan, a year-on-year decrease of 14.33%. The basic earnings per share were 0.18 yuan
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments